Full Text
PMDH3- THE USE OF SURROGATE ENDPOINT DATA IN EVALUATING TREATMENT EFFICACY- IMPACT ON DECISION-MAKING AND EXPENDITURE WITHIN THE AUSTRALIAN PHARMACEUTICAL BENEFITS SCHEME

Abstract

Authors

R Lopert SR Hill DA Henry

Back to Volume 3, Issue 5
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×